Spa Therapy Efficacy in Mental Health and Sleep Quality Disorders in Patients with a History of COVID-19: A Comparative Study
- PMID: 39452476
- PMCID: PMC11507196
- DOI: 10.3390/diseases12100232
Spa Therapy Efficacy in Mental Health and Sleep Quality Disorders in Patients with a History of COVID-19: A Comparative Study
Abstract
The COVID-19 pandemic has left behind mental health issues like anxiety, depression, and sleep disorders among survivors. This study assessed the efficacy of spa therapy in enhancing psychological well-being and sleep quality in individuals with chronic arthro-rheumatic, respiratory, and otorhinolaryngological diseases, including COVID-19 recoverees. Our prospective observational study included 144 Caucasian subjects from three Italian spas who underwent a 2-week spa therapy cycle, involving balneotherapy and/or inhalation treatments. Symptoms were assessed with the Visual Analogue Scale (VAS), psychological well-being with Depression Anxiety Stress Scales-21 items (DASS-21), and sleep quality with the Insomnia Severity Index (ISI). Significant reductions in VAS scores for arthro-rheumatic, respiratory, and otorhinolaryngological symptoms were observed after spa therapy, as well as for DASS-21 and ISI scores for sleep quality, transitioning to less severe insomnia categories. Females had more pronounced improvements in DASS-21 scores and sleep quality. Subjects with and without prior SARS-CoV-2 infection experienced significant reductions in anxiety, depression, and stress, with more pronounced improvements in those without prior infection. COVID-19 survivors also showed significant ISI score improvements. Spa therapy is a promising complementary treatment for improving mental health and sleep quality in chronic disease patients, including COVID-19 survivors.
Keywords: COVID-19; anxiety; depression; sleep disorders; spa therapy.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130–140. doi: 10.1016/S2215-0366(20)30462-4. Erratum in Lancet Psychiatry 2021, 8, e1. - DOI - PMC - PubMed
-
- Colizzi M., Peghin M., De Martino M., Bontempo G., Gerussi V., Palese A., Isola M., Tascini C., Balestrieri M. Mental health symptoms one year after acute COVID-19 infection: Prevalence and risk factors. Rev. Psiquiatr. Y Salud Ment. 2023;16:38–46. doi: 10.1016/j.rpsm.2022.05.008. - DOI - PMC - PubMed
-
- Seighali N., Abdollahi A., Shafiee A., Amini M.J., Teymouri Athar M.M., Safari O., Faghfouri P., Eskandari A., Rostaii O., Salehi A.H., et al. The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): A systematic review and meta-analysis. BMC Psychiatry. 2024;24:105. doi: 10.1186/s12888-023-05481-6. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
